NEW YORK (GenomeWeb News) – Vermillion and Accelerate Diagnostics saw their share prices more than double during the first six months of 2013, pacing the GenomeWeb Daily News Index for the first half of the year.

Overall, the index was up nearly 17 percent from the end of 2012, beating the Dow Jones Industrial Average (+14 percent) and the Nasdaq Composite (+13 percent), but trailing the Nasdaq Biotech Index (+27 percent).

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.